Press Release

Global Anatomic Pathology Market is Expected to Grow at a CAGR of 5.9% in the Forecast Period of 2022-2027.

Anatomic Pathology Market

According to a new report by EMR titled, ‘Global Anatomic Pathology Market Report and Forecast 2022-2027’, the global anatomic pathology market was estimated to be USD 16.1 billion in 2020 and is expected to grow at a CAGR of 5.9% over the forecast period of 2022-2027.

The global anatomic pathology market is divided geographically into North America, Europe, the Asia Pacific, and the others. In 2020, the largest market share was represented by North America, followed by Europe. The growth of the anatomical pathology market in North America is driven by factors like the growing prevalence of chronic diseases, growing health expenditure, high-quality infrastructures for hospitals and clinical laboratories, as well as the presence of key players in the regions.

In November 2018, one of the key players, Quest Diagnostics Incorporated (NYSE: DGX), announced the acquisition of the assets of the Boyce and the Bynum Pathology Laboratories (BBPL), a leading diagnosis and clinical laboratory services provider in the Midwest. The BBPL / Quest partnership would result in a broader range of clinical laboratory and anatomical pathology facilities across the United States. In addition, the partnership would provide patients with more convenient access to an expanded network of service centres throughout the Midwest. This has aided the growth of the global anatomic pathology market and is likely to continue favouring the market development in the forecast period as well.

The technological advancements and innovations in the industry are also aiding the global anatomic pathology market growth. In September 2018, Sakura Finetek USA, Inc., another key player, unveiled the manual microtome Accu-Cut SRM 300 LT, an integrated4-color LED rear illumination 3D precision chuck, a new feature which allows for the more simplified observation of paraffin-embedded tissue samples for the rapid display of translucent biopsies.

Market Analysis by Product and Service, Application, End Use, and Regions:

  • On the basis of product and service, the market is divided into instruments, consumables, and services. Instruments can be further divided into microtomes and cryostat, tissue processor, automatic stainers, and other products. Consumables are segmented into reagents and antibodies, probes and kits, and others.
  • It finds application in disease diagnosis, drug discovery and development, and others.
  • The end-uses of anatomic pathology include research laboratories, hospitals, and diagnostic laboratories, among others.
  • The regional markets include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The global anatomic pathology market growth is propelled by the growing dependence on biomarker pathology tests and procedures for specific malignancies and tumorigenesis.
  • High use of advanced pathology technologies like staining technologies, gross imaging, as well as optical microscopes, are boosting the market growth.
  • Digital imaging innovations provide accuracy and precision-based advantages over conventional methods while increasing the overall product growth rates in the market.
  • The advanced clinical use of biomarkers allows pathologists to determine disease pathogenesis at a molecular level to make therapeutic decisions to improve patient outcomes, further catalysing the growth of the market.

Key Offerings of the Report:

  • The EMR report gives an overview of the global anatomic pathology market for the periods (2017-2021) and (2022-2027).
  • The report also offers the historical (2017-2021) and forecast (2022-2027) markets for the product and service, application, end use, and major regional markets of anatomic pathology.
  • It assesses the market based on the SWOT and Porter’s Five Forces models.

The major key players in the global anatomic pathology market include companies like Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Cardinal Health, Agilent Technologies, Inc., and Sakura Finetek USA, Inc., among others. The comprehensive report covers their market share, capacity, and latest developments like mergers and acquisitions, and capacity expansions.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.